Skip To Main Content
Bardia Abbasi on Muck Rack

Bardia Abbasi

As seen in: JAMA (The Journal of the American Medical Association)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bardia

Contact Bardia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

|
By Jimena Tatiana Hathaway, Madhura P. Shah, David Hathaway, Seyedeh Maryam Zekavat, Drenushe Krasniqi, John W. Gittinger, Dean Cestari, Robert M. Mallery, Bardia Abbasi, Marc A. Bouffard, Bart K. Chwalisz, Tais Estrela, Joseph Rizzo
| JAMA (The Journal of the American Medical Association) Verified
Supplement. Figure 1. Cohort Selection (opens in new tab) The flow diagram shows the cohort selection for the analysis of the risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients treated with semaglutide vs a non–glucagon-like peptide 1 receptor agonist (GLP-1 RA) either for type 2 diabetes or for overweight or obesity.
Open in Who Shared Issue with article?
See all 1 articles